Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA04000032 17-HDoHE cPLA2i 1.0 BCD110605C28 0.261 pmol/ml medium
LMFA04000032 17-HDoHE cPLA2i 1.0 BCD110605C30 0.251 pmol/ml medium
LMFA04000032 17-HDoHE cPLA2i 1.0 BCD110605C29 0.306 pmol/ml medium
LMFA04000032 17-HDoHE cPLA2i 20.0 BCD110605C64 0.524 pmol/ml medium
LMFA04000032 17-HDoHE cPLA2i 20.0 BCD110605C66 0.517 pmol/ml medium
LMFA04000032 17-HDoHE cPLA2i 20.0 BCD110605C65 0.401 pmol/ml medium
LMFA04000032 17-HDoHE PLDi 1.0 BCD110605C16 0.277 pmol/ml medium
LMFA04000032 17-HDoHE PLDi 1.0 BCD110605C17 0.243 pmol/ml medium
LMFA04000032 17-HDoHE PLDi 1.0 BCD110605C18 0.235 pmol/ml medium
LMFA04000032 17-HDoHE PLDi 20.0 BCD110605C54 0.458 pmol/ml medium
LMFA04000032 17-HDoHE PLDi 20.0 BCD110605C52 0.549 pmol/ml medium
LMFA04000032 17-HDoHE PLDi 20.0 BCD110605C53 0.525 pmol/ml medium
LMFA04000032 17-HDoHE KDO+cPLA2i 1.0 BCD110605C32 0.221 pmol/ml medium
LMFA04000032 17-HDoHE KDO+cPLA2i 1.0 BCD110605C31 0.322 pmol/ml medium
LMFA04000032 17-HDoHE KDO+cPLA2i 1.0 BCD110605C33 0.232 pmol/ml medium
LMFA04000032 17-HDoHE KDO+cPLA2i 20.0 BCD110605C68 0.39 pmol/ml medium
LMFA04000032 17-HDoHE KDO+cPLA2i 20.0 BCD110605C69 0.451 pmol/ml medium
LMFA04000032 17-HDoHE KDO+cPLA2i 20.0 BCD110605C67 0.475 pmol/ml medium
LMFA04000032 17-HDoHE KDO+PLDi 1.0 BCD110605C19 0.245 pmol/ml medium
LMFA04000032 17-HDoHE KDO+PLDi 1.0 BCD110605C20 0.251 pmol/ml medium
LMFA04000032 17-HDoHE KDO+PLDi 1.0 BCD110605C21 0.243 pmol/ml medium
LMFA04000032 17-HDoHE KDO+PLDi 20.0 BCD110605C56 0.428 pmol/ml medium
LMFA04000032 17-HDoHE KDO+PLDi 20.0 BCD110605C57 0.472 pmol/ml medium
LMFA04000032 17-HDoHE KDO+PLDi 20.0 BCD110605C55 0.574 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.276 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.22 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.248 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.26 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.297 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.254 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+PLDi 1.0 BCD110605C25 0.234 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+PLDi 1.0 BCD110605C27 0.292 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+PLDi 1.0 BCD110605C26 0.283 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+PLDi 20.0 BCD110605C61 0.264 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+PLDi 20.0 BCD110605C62 0.239 pmol/ml medium
LMFA04000032 17-HDoHE KDO+ATP+PLDi 20.0 BCD110605C63 0.25 pmol/ml medium
LMFA04000032 17-HDoHE KDO + ATP 1.0 BCD110605C15 0.251 pmol/ml medium
LMFA04000032 17-HDoHE KDO + ATP 1.0 BCD110605C14 0.245 pmol/ml medium
LMFA04000032 17-HDoHE KDO + ATP 1.0 BCD110605C13 0.229 pmol/ml medium
LMFA04000032 17-HDoHE KDO + ATP 20.0 BCD110605C49 0.281 pmol/ml medium
LMFA04000032 17-HDoHE KDO + ATP 20.0 BCD110605C50 0.276 pmol/ml medium
LMFA04000032 17-HDoHE KDO + ATP 20.0 BCD110605C51 0.277 pmol/ml medium
LMFA04000032 17-HDoHE KDO 1.0 BCD110605C08 0.284 pmol/ml medium
LMFA04000032 17-HDoHE KDO 1.0 BCD110605C07 0.24 pmol/ml medium
LMFA04000032 17-HDoHE KDO 1.0 BCD110605C09 0.303 pmol/ml medium
LMFA04000032 17-HDoHE KDO 20.0 BCD110605C45 0.532 pmol/ml medium
LMFA04000032 17-HDoHE KDO 20.0 BCD110605C44 0.454 pmol/ml medium
LMFA04000032 17-HDoHE KDO 20.0 BCD110605C43 0.508 pmol/ml medium
LMFA04000032 17-HDoHE C 0.0 BCD110605C03 0.256 pmol/ml medium
LMFA04000032 17-HDoHE C 0.0 BCD110605C01 0.224 pmol/ml medium